Selected pre-clinical literature.
Citations are provided for reference only and do not constitute therapeutic claims. Zenitide makes no representation regarding the applicability of pre-clinical findings to human or veterinary use.
Stable gastric pentadecapeptide BPC 157 and tendon healing: an outline of pre-clinical evidence
Sikiric P. et al.
Pre-clinical review
Thymosin β4 promotes angiogenesis and tissue repair: mechanisms in vascular endothelial cells
Goldstein A. L., Hannappel E., Kleinman H. K.
Mechanism review
Ipamorelin, the first selective growth hormone secretagogue without effect on cortisol or prolactin
Raun K. et al.
Pharmacology
Tesamorelin, a GHRH analogue, in studies of growth-hormone axis regulation
Ferdinandi E. S. et al.
Pre-clinical
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration
Pickart L., Margolina A.
Mechanism review
Sustained-release GHRH analogue CJC-1295: pharmacokinetic and pharmacodynamic profile
Teichman S. L. et al.
PK/PD
Citations are provided for reference only and do not constitute therapeutic claims. Zenitide makes no representation regarding the applicability of pre-clinical findings to human or veterinary use.
Ready to order?
Verified researchers and institutional buyers can add items to their basket here and proceed to secure checkout when ready.
Frequently asked questions
No. Citations are for reference only and do not constitute therapeutic claims. Zenitide makes no representation regarding the applicability of pre-clinical findings to human or veterinary use.
Yes — email info@zenitide.co.uk with the compound and research area.
Every shipment includes a per-lot Certificate of Analysis containing HPLC trace and mass spectrometry report.